ClinicalTrialsFinder
RecruitingPhase 4NCT04935021

Clinical Study of ATTR-CM

Clinical Study Protocol of Transthyroxine Protein Amyloidosis Cardiomyopathy and Its Gene Carriers

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Enrollment

100 participants

Start Date

Jun 1, 2021

Study Type

INTERVENTIONAL

Conditions

Transthyroxine Amyloidosis Cardiomyopathy

Summary

In this study, patients with ATTR-CM or gene carriers were selected to study the diagnosis and treatment, and long-term follow-up was conducted.

Eligibility

Min Age: 18 YearsMax Age: 80 Years

Inclusion Criteria2

  • Patients and gene carriers of ATTR-CM confirmed in the Second Affiliated Hospital of Zhejiang University School of Medicine, regardless of gender, age 18-90 years old;
  • Patients who have the ability to understand the test and can cooperate with investigators

Exclusion Criteria1

  • Patients who unable to understand or unwilling to fill in informed consent forms or follow visitors

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGATTR-CM

Current treatment

Locations(1)

xiaohong University PAN

Hangzhou, Zhejiang, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04935021